Legend Biotech Corp Stock Performance

LEGN Stock  USD 58.93  0.19  0.32%   
On a scale of 0 to 100, Legend Biotech holds a performance score of 11. The company secures a Beta (Market Risk) of 0.58, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Legend Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Legend Biotech is expected to be smaller as well. Please check Legend Biotech's jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Legend Biotech's current price movements will revert.

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Legend Biotech Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Legend Biotech displayed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
0.86
Five Day Return
6.8
Year To Date Return
(0.61)
Ten Year Return
58.76
All Time Return
58.76
1
Legend Biotech Q1 2024 Earnings Preview
05/10/2024
2
JJ, Legend release promising results on Carvykti in earlier treatment line
06/03/2024
3
The Manufacturers Life Insurance Company Has 36.64 Million Position in Legend Biotech Co. - MarketBeat
06/07/2024
4
Hhlr Advisors LTD. Has 360.09 Million Stock Holdings in Legend Biotech Co. - MarketBeat
06/12/2024
5
Johnson Johnsons Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
07/02/2024
6
Rock star Growth Puts Legend Biotech In A Position To Use Debt
07/05/2024
7
Legend Biotech Up 12 percent on Reports of Takeover Bid
07/15/2024
Begin Period Cash Flow787.3 M
  

Legend Biotech Relative Risk vs. Return Landscape

If you would invest  4,517  in Legend Biotech Corp on April 24, 2024 and sell it today you would earn a total of  1,376  from holding Legend Biotech Corp or generate 30.46% return on investment over 90 days. Legend Biotech Corp is currently generating 0.4924% in daily expected returns and assumes 3.3762% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than Legend, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Legend Biotech is expected to generate 5.15 times more return on investment than the market. However, the company is 5.15 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

Legend Biotech Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Legend Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Legend Biotech Corp, and traders can use it to determine the average amount a Legend Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1458

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsLEGN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.38
  actual daily
30
70% of assets are more volatile

Expected Return

 0.49
  actual daily
9
91% of assets have higher returns

Risk-Adjusted Return

 0.15
  actual daily
11
89% of assets perform better
Based on monthly moving average Legend Biotech is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Legend Biotech by adding it to a well-diversified portfolio.

Legend Biotech Fundamentals Growth

Legend Stock prices reflect investors' perceptions of the future prospects and financial health of Legend Biotech, and Legend Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Legend Stock performance.

About Legend Biotech Performance

By examining Legend Biotech's fundamental ratios, stakeholders can obtain critical insights into Legend Biotech's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Legend Biotech is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 43.08  45.23 
Return On Tangible Assets(0.31)(0.32)
Return On Capital Employed(0.27)(0.28)
Return On Assets(0.28)(0.29)
Return On Equity(0.41)(0.43)

Things to note about Legend Biotech Corp performance evaluation

Checking the ongoing alerts about Legend Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Legend Biotech Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Legend Biotech Corp had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 285.14 M. Net Loss for the year was (518.25 M) with loss before overhead, payroll, taxes, and interest of (284.01 M).
Legend Biotech Corp currently holds about 791.26 M in cash with (384.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Latest headline from zacks.com: Legend Biotech Up 12 percent on Reports of Takeover Bid
Evaluating Legend Biotech's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Legend Biotech's stock performance include:
  • Analyzing Legend Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Legend Biotech's stock is overvalued or undervalued compared to its peers.
  • Examining Legend Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Legend Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Legend Biotech's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Legend Biotech's stock. These opinions can provide insight into Legend Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Legend Biotech's stock performance is not an exact science, and many factors can impact Legend Biotech's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Information and Resources on Investing in Legend Stock

When determining whether Legend Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotech Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.58)
Revenue Per Share
1.902
Quarterly Revenue Growth
1.587
Return On Assets
(0.18)
Return On Equity
(0.51)
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.